new_0222_0383|DAWN|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0383|DAWN|Long Name|1|1|Day One Biopharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Day One Biopharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Day One Biopharmaceuticals Inc Inventories (Quarterly) (USD)|Day One Biopharmaceuticals Inc Net PP&E (Quarterly) (USD)|Day One Biopharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Deposits (Quarterly) (USD)|Day One Biopharmaceuticals Inc Book Value (Quarterly) (USD)|Day One Biopharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Day One Biopharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Day One Biopharmaceuticals Inc EV to Revenues|Day One Biopharmaceuticals Inc EV to Earnings|Day One Biopharmaceuticals Inc EV to Free Cash Flow|Day One Biopharmaceuticals Inc EV to Assets (Quarterly)|Day One Biopharmaceuticals Inc PS Ratio|Day One Biopharmaceuticals Inc PE Ratio|Day One Biopharmaceuticals Inc Price to Book Value|Day One Biopharmaceuticals Inc PEG Ratio|Day One Biopharmaceuticals Inc Debt to Equity Ratio|Day One Biopharmaceuticals Inc Dividend Yield|Day One Biopharmaceuticals Inc Shareholder Yield (TTM)|Day One Biopharmaceuticals Inc Percent of Shares Outstanding Short|Day One Biopharmaceuticals Inc Total Receivables (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Payables (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Day One Biopharmaceuticals Inc Return on Invested Capital|Day One Biopharmaceuticals Inc Quality Ratio Score|Day One Biopharmaceuticals Inc Momentum Score|Day One Biopharmaceuticals Inc Beta (1Y)|Day One Biopharmaceuticals Inc Sustainable Growth Rate (TTM)|Day One Biopharmaceuticals Inc Institutional Investor Ownership Percentage|Day One Biopharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Day One Biopharmaceuticals Inc Total Employees (Annual)|Day One Biopharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Day One Biopharmaceuticals Inc Shares Outstanding|Day One Biopharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Day One Biopharmaceuticals Inc Ordinary Shares Number (Quarterly)|Day One Biopharmaceuticals Inc Payout Ratio|Day One Biopharmaceuticals Inc Quick Ratio (Quarterly)|Day One Biopharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Day One Biopharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Day One Biopharmaceuticals Inc Effective Tax Rate (TTM)|Day One Biopharmaceuticals Inc Return on Equity|Day One Biopharmaceuticals Inc Net Income (TTM) (USD)|Day One Biopharmaceuticals Inc Revenue (TTM) (USD)|Day One Biopharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Day One Biopharmaceuticals Inc Revenue (Quarterly) (USD)|Day One Biopharmaceuticals Inc Gross Profit (Quarterly) (USD)|Day One Biopharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Day One Biopharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Day One Biopharmaceuticals Inc Net Income (Quarterly) (USD)|Day One Biopharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Day One Biopharmaceuticals Inc Price (USD)|Day One Biopharmaceuticals Inc Total Return Price (USD)|Day One Biopharmaceuticals Inc Enterprise Value (USD)|Day One Biopharmaceuticals Inc 30-Day Average Daily Volume|Day One Biopharmaceuticals Inc 1 Year Price Returns (Daily)
new_0222_0383|DAWN|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0383|DAWN||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0383|DAWN||5|5|91.25|91.25|0|91.25|0|91.25|91.25|91.25|0|91.25|91.25|0|0|0|1.44607843137|0|0|0|1.44198895028|0|0|1.44607843137|0|15.3333333333|0|91.25|91.25|0|0|0|0|0|30.3333333333|91.4285714286|137.5|91.4285714286|28.7|0|91.25|0|0|91.4285714286|91.5|0|0|91.25|0|0|0|0|91.4285714286|91.4285714286|91.4285714286|91.4285714286|1.44607843137|1.44607843137|1.44607843137|1.44|0
new_0222_0383|DAWN||6|6|4|4|0|4|0|4|4|4|0|4|4|0|0|0|204|0|0|0|181|0|0|204|0|18|0|4|4|0|0|0|0|0|9|7|2|7|10|0|4|0|0|7|6|0|0|4|0|0|0|0|7|7|7|7|204|204|204|175|0
new_0222_0383|DAWN||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0383|DAWN|202003|202003|202003||||||||||||||||||||||||||||||||||42.031||-0.0365||||||-0.0313|||||||||0.808|-1.992|-1.535|-0.003|||||
new_0222_0383|DAWN|202006|202006|202006||||||||||||||||||||||||||||||||||42.031||-0.0419||||||-0.0397|0||||||||0.872|-2.409|-1.76|-0.01|||||
new_0222_0383|DAWN|202009|202009|202009||||||||||||||||||||||||||||||||||42.031||-0.0672||||||-0.0607|0||||||||1.024|-3.842|-2.824|-0.009|||||
new_0222_0383|DAWN|202012|202012|202012|45.071|43.728||0.483||94.164|1.996|92.168||-54.205|-56.842|||||||||||||||0.202|2|||||||42.031||-0.8179|||60.3374|||-0.1179|0|||-40.496|||||1.979|-35.6|-34.377|-0.008|||||
new_0222_0383|DAWN|202103|202103|202103|158.755|154.87||0.435||224.946|3.066|221.88||-68.849|-72.024|||||||||||||||0.686|2|||||||42.031|20|-0.38|||60.3374|||-0.38||||-54.143|||||3.454|-16.101|-15.182|-0.007|||||
new_0222_0383|DAWN|202105|202103|202103|||||||||||||||-43.9599|||||||0||0|||||||||12.8073||||60.4289||||||||||||||||||23.69|23.69|1281.4736||
new_0222_0383|DAWN|202106|202106|202106|316.025|309.996||0.386||4.774|4.662|0.112||311.763|-86.308||||-27.054||||4.5231|||0||1.4606||0.348|0.006||||||65.4663|22.6619||-5.04|61.9289||61.9289|||-5.04|-167.66|||-66.665|||||5.525|-15.473|-14.282|-0.007|22.77|22.77|1100.1251||
new_0222_0383|DAWN|202107|202106|202106|||||||||||||||-28.5008||||4.7118|||0||1.9037|||||||||65.6748||||61.9289||||||||||||||||||23.72|23.72|1158.9575|68905.2667|
new_0222_0383|DAWN|202108|202106|202106|||||||||||||||-34.7601||||5.5282|||0||2.509|||||||||65.7601||||||||||||||||||||||27.83|27.83|1413.4853|89265.7333|
new_0222_0383|DAWN|202109|202109|202109|303.311|297.16||0.335||6.111|6.046|0.065||297.672|-105.548||||-23.7778||||4.9369|||0||2.8738||0.683|0.006||||||69.7795|57.5142|42|-0.33|61.9289||61.9289|||-0.33|0.615|||-83.081|||||9.392|-19.24|-19.24|-0.006|23.73|23.73|1172.4128|153758.7333|
new_0222_0383|DAWN|202110|202109|202109|||||||||||||||-24.6696||||5.0846|||0||3.0214|||||||||69.8587||||61.9289||||||||||||||||||24.44|24.44|1216.3823|60716.3667|
new_0222_0383|DAWN|202111|202109|202109|||||||||||||||-17.0457||||3.8218|||0||3.0824|||||||||70.0162||||||||||||||||||||||18.37|18.37|840.4739|84726.6|
new_0222_0383|DAWN|202112|202112|202112|289.368|284.309||0.284||8.673|8.657|0.016||281.148|-127.487||||-13.4347||||3.713|||0||5.5566||1.744|0.006||||||93.414|61.9523|55|-0.3541|61.9523||61.9523|||-0.3541|-0.318|||-70.642|||||10.786|-21.938|-21.938|0.023|16.85|16.85|759.5873|308964.5333|
new_0222_0383|DAWN|202201|202112|202112|||||||||||||||-11.1276||||3.249|||0||6.1042|||||||||93.174||||61.9289||||||||||||||||||14.75|14.75|629.1423|298732.9667|
new_0222_0383|DAWN|202202|202112|202112|||||||||||||||-9.9337||||3.0089|||0||6.4374|||||||||93.1458||||||||||||||||||||||13.66|13.66|561.6398|213289.5|
new_0222_0383|DAWN|202203|202203|202203|||||||||||||||-6.9572||||2.4103|||0|||||||||||||||62||||||||||||||||||10.93|10.93|393.351|242109.3|